Loading...

Secular Trends Will Expand Global Adoption Of PEDMARK In Oncology

Published
28 May 25
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
97.0%
7D
-1.5%

Author's Valuation

US$1547.6% undervalued intrinsic discount

AnalystHighTarget Fair Value